BP Haynes

565 total citations
8 papers, 433 citations indexed

About

BP Haynes is a scholar working on Nutrition and Dietetics, Pharmacology and Oncology. According to data from OpenAlex, BP Haynes has authored 8 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nutrition and Dietetics, 4 papers in Pharmacology and 2 papers in Oncology. Recurrent topics in BP Haynes's work include Vitamin K Research Studies (6 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Poisoning and overdose treatments (2 papers). BP Haynes is often cited by papers focused on Vitamin K Research Studies (6 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Poisoning and overdose treatments (2 papers). BP Haynes collaborates with scholars based in United Kingdom and United States. BP Haynes's co-authors include AM Breckenridge, S. Cholerton, BK Park, AK Scott, R G Malía, F E Preston, Mitch Dowsett, S. Johnston, Michael Jarman and SR Ebbs and has published in prestigious journals such as The Lancet, Cancer Research and British Journal of Clinical Pharmacology.

In The Last Decade

BP Haynes

8 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
BP Haynes United Kingdom	8	170	106	91	89	65	8	433
Rosa D’Ambrosio Italy	7	514 3.0×	82 0.8×	105 1.2×	26 0.3×	83 1.3×	9	702
P Perna Italy	6	492 2.9×	79 0.7×	95 1.0×	35 0.4×	77 1.2×	12	668
Rita Barallon United Kingdom	6	218 1.3×	16 0.2×	102 1.1×	70 0.8×	34 0.5×	9	427
Elizabeth Sconce United Kingdom	5	701 4.1×	186 1.8×	249 2.7×	37 0.4×	91 1.4×	7	972
Katja Sittinger Germany	5	246 1.4×	76 0.7×	41 0.5×	9 0.1×	27 0.4×	5	308
L. Korsgaard Christensen Denmark	12	146 0.9×	36 0.3×	55 0.6×	26 0.3×	85 1.3×	41	820
Tsuyoshi Mikkaichi Japan	17	151 0.9×	66 0.6×	73 0.8×	49 0.6×	544 8.4×	24	996
H. J. Gilfrich Germany	9	63 0.4×	20 0.2×	82 0.9×	14 0.2×	23 0.4×	26	289
Michael H. Buonarati United States	15	92 0.5×	17 0.2×	32 0.4×	13 0.1×	80 1.2×	25	581
Christian Tschanz United States	14	86 0.5×	35 0.3×	13 0.1×	8 0.1×	45 0.7×	18	383

Countries citing papers authored by BP Haynes

Since Specialization

Citations

This map shows the geographic impact of BP Haynes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by BP Haynes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites BP Haynes more than expected).

Fields of papers citing papers by BP Haynes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by BP Haynes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by BP Haynes. The network helps show where BP Haynes may publish in the future.

Co-authorship network of co-authors of BP Haynes

This figure shows the co-authorship network connecting the top 25 collaborators of BP Haynes. A scholar is included among the top collaborators of BP Haynes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with BP Haynes. BP Haynes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Drury, Suzanne, Vered Stearns, BP Haynes, et al.. (2010). Abstract S1-7: Lack of Correlation between Gene Variants in Tamoxifen Metabolizing Enymes with Primary Endpoints in the ATAC Trial.. Cancer Research. 70(24_Supplement). S1–7. 40 indexed citations

2.

Johnston, S., Mitch Dowsett, IE Smith, et al.. (1993). Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentration. The Lancet. 342(8886-8887). 1521–1522. 65 indexed citations

3.

Malía, R G, BP Haynes, S. Cholerton, et al.. (1988). The relationship between inhibition of vitamin K1 2,3‐epoxide reductase and reduction of clotting factor activity with warfarin.. British Journal of Clinical Pharmacology. 25(1). 1–7. 73 indexed citations

4.

Haynes, BP, et al.. (1986). Enantiomers of warfarin and vitamin K1 metabolism.. British Journal of Clinical Pharmacology. 22(6). 729–732. 49 indexed citations

5.

Haynes, BP, et al.. (1986). Abnormal vitamin K metabolism in the presence of normal clotting factor activity in factory workers exposed to 4‐hydroxycoumarins.. British Journal of Clinical Pharmacology. 21(3). 289–293. 34 indexed citations

6.

Cholerton, S., et al.. (1986). Stereoselective interaction between the R enantiomer of warfarin and cimetidine.. British Journal of Clinical Pharmacology. 21(3). 271–277. 76 indexed citations

7.

Scott, AK, et al.. (1985). Vitamin K1 metabolism in relation to pharmacodynamic response in anticoagulated patients.. British Journal of Clinical Pharmacology. 20(6). 643–648. 29 indexed citations

8.

Park, BK, et al.. (1984). Plasma disposition of vitamin K1 in relation to anticoagulant poisoning.. British Journal of Clinical Pharmacology. 18(5). 655–662. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact